ADVERTISEMENT

Pediatrics

Medical Groups Dismiss Trump’s ‘Event On Autism’

Among critics of Trump administration's moves, American Academy of Pediatrics says “White House event on autism was filled with dangerous claims and misleading information.”

Attorney For Autistic Children’s Families: Additional Acetaminophen Label Warning Not Needed

“I knew when I was pregnant with my kids the first thing, I knew from just talking to my other friends, before you take anything when you're pregnant, you go to talk to your doctor. I think that's what most pregnant women do,” says regulatory attorney Christine Lawson.

Trump Warns Of Acetaminophen-Autism Link As FDA Starts Process To Add OTC Label Warning

Agency following what Commissioner Martin Makary says is President Trump’s instruction to “do what's medically right, to go bold and not worry about the corporations and the lobbyists.”

MAHA Commission’s Healthy Children Strategy Report Fails Supplement Industry’s Assessment

To supplement industry, MAHA’s “Make Our Children Healthy Again” Strategy Report stands out more for what it doesn’t say than what it does. Another omission is anything about HHS Secretary Kennedy’s focus on potential link between pregnant women’s use of acetaminophen and children's autism.

MAHA Healthy Children Strategy Report Likely To Claim Link Between Acetaminophen And Autism

MAHA meeting announcement followed reports that HHS Secretary Robert F. Kennedy Jr. planned in September to release report on potential link to autism from pregnant women’s use of OTC acetaminophen.

‘FDA Approved’ Not An Ad Claim Infant Formula Can Use, NAD Review Finds

NAD attorneys find Kendal Nutricare can continue using “natural” ad claims with limits for Kendamil formula but also conclude some research it submitted to support other claims wasn’t appropriate because the studies didn’t test its products.

How Notified Bodies Would Like Future EU Medtech Governance To Pan Out

Notified bodies are calling for their key role, as the technical, regulatory and clinical ‘extended arm’ of regulatory authorities, to remain central to the EU medtech conformity assessment process.

Commission Decision Launches Pediatric And Rare Disease Expert Group

A revised annex to the original decision also outlines expert remuneration limits and introduces further changes.

MAHA Commission Outlines Enhanced Research On Drug Safety In Children

Research would include initiatives on reproducing industry-sponsored studies, postmarket surveillance, and studies of long-term neurodevelopmental and metabolic outcomes for commonly prescribed pediatric drugs.

Plans For Specific EU Orphan And Pediatric Device Expert Panel Need To Go Further

Moves are at last underway for a more specific focus on orphan and pediatric devices. They are a start; but experts are calling for more to support this sector.

Commission Led By HHS Secretary Kennedy Will Probe ‘Threats’ To Children, Including Medicines

President Trump's Executive Order creating the commission names mental health and weight-loss drugs as treatments of concern. But it does not mention vaccines, which Kennedy has criticized.

USANA’s $205M Majority Stake In Hiya Brings ‘Kidsperience’ And Direct-To-Consumer Sales

Hiya has more than 200,000 customers in the direct-to-consumer channel, all using subscriptions ordered on the brand’s website, and plans to expand into online marketplaces and retail chains. The startup “offers a compelling subscription model with attractive margins, profitability, and strong cash flow generation,” says USANA CEO Jim Brown.